Sunesis Pharmaceuticals, Inc.
(NASDAQ:SNSS)|
0.340 0.000 (0.00%) Jan 07 - Close |
|
|
|
After-Hours 0.39 +0.05 (14.71%) Thu, 8 Jan 2009 7:40 PM
- Compare SNSS with:
- View: Line | Candlestick
Company Profile
Sunesis Pharmaceuticals, Inc.
395 Oyster Point Boulevard
South San Francisco, CA 94080
United States - Map
Phone: (650) 266-3500
Fax: (650) 266-3505
Website: www.sunesis.com
CEO: Daniel N. Swisher, Jr.
Employees: 105
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Biopharm. co. focused on therapeutics for oncology
A biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for use in oncology and other serious diseases.
Recent news for SNSS
-
EDGAR Online - Dec 23 2008 at 6:03 ET
-
Sunesis says early AML trial results promising
Reuters - Dec 07 2008 at 12:00 ET
-
PR Newswire - Dec 07 2008 at 12:00 ET
-
Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH
PR Newswire - Dec 01 2008 at 8:00 ET
-
Sunesis to Present at Upcoming Conferences
PR Newswire - Nov 25 2008 at 8:00 ET
-
SUNESIS PHARMACEUTICALS INC Financials
EDGAR Online Financials - Nov 13 2008 at 9:04 ET
-
SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Termination of a Material Definitive Agreement
EDGAR Online - Nov 12 2008 at 3:02 ET
-
SUNESIS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online - Nov 07 2008 at 2:13 ET
-
EDGAR Online - Nov 06 2008 at 3:21 ET
-
PR Newswire - Nov 06 2008 at 8:30 ET